Introduction {#s1}
============

The researcher suggests that the oxidation of low lipid lipoproteins (ox-LDL) is considered as the important marker of inflammatory reaction. ox-LDL has been well known to boost the pro-inflammatory cytokines leading to monocyte infiltration into the vessel walls ([@B9]; [@B1]; [@B39]). Research suggests that the generation of ox-LDL during the oxidative stress condition enhanced the reactive oxygen species (ROS) production, which further gathers in macrophages and other cells and creates the chronic inflammatory condition ([@B4]; [@B28]; [@B47]). Ox-LDL also boosts the inflammatory reaction and oxidative stress to the vascular endothelium ([@B34]; [@B83]). It also exerts the atherosclerotic plaque progression and formation and enhances the secretion and synthesis of adhesion molecules, adhesion, and monocyte chemotaxis ([@B25]; [@B82]); ox-LDL enhanced the smooth muscle cell proliferation and amplify foam cell formation, endothelial cell apoptosis, matrix degradation, and oozing of matrix metalloproteinases (MMP) arbitrating the degradation protein components of extracellular matrix and basement membrane in target cells ([@B78]; [@B25]; [@B65]; [@B51]; [@B95]).

The researcher suggests that it also increased the overexpression of adhesion molecule on the endothelial cell surface and also enhanced the monocytes to the arterial wall of endothelial dysfunction ([@B41]). Endothelial dysfunction has been considered as a significant factor for the progression of cardiovascular diseases. Endothelial dysfunction could induce platelet adhesion and cardiovascular inflammation (CVD) especially atherosclerosis (AS) ([@B10]; [@B77]; [@B61]). The report suggests that the CVD majorly leading the cause of mortality and morbidity worldwide and approximately 16 million death has been reported annually ([@B30]; [@B35]; [@B26]). CVD disease, mainly AS is a chronic disease of the arterial vessel wall, started *via* deposition of lipoproteins in the intimal layer of the vascular wall ([@B69]; [@B37]; [@B68]). AS is responsible for a large number of casualties related to cardiovascular-related disease ([@B53]; [@B80]). AS is a chronic and complex inflammatory disease, which is described by the abnormal deposition of lipids and fibrous elements into the arteries ([@B38]). It is frequently asymptomatic for several decades until the incidence of serve CVD such as heart attack or stroke ([@B38]). Oxidized lipids are responsible for the onset of expression of a set of genes that cause the chronic inflammatory reaction, leading to the deposition of oxidized lipids within the vessel wall ([@B20]; [@B31]). Due to deposition of oxidized lipids inside, the vessel wall was able to increase the expression of transcription factors genes, *viz*., nuclear factor κB (NF-κB), to induce the chronic inflammatory reaction ([@B14]; [@B5]). Research suggests that the inflammatory process involved in every step of AS starts from the damaging in a vessel of endothelial cells to burst of plaque at the end-stage ([@B75]; [@B44]). During the progression of AS, the formation of foam cells (lipid-laden macrophages) plays a significant role in the retort to inflammation linked stimuli ([@B16]; [@B44]). Usually, the formation of the above disease is related to the hyperlipidemia and unusual deposition of ox-LDL ([@B2]; [@B36]). Research suggests that the ox-LDL damaged the endothelial function resultant, increased the production of ROS, and reduced the production of nitric oxide (NO) ([@B66]; [@B54]). Additionally, continue generation of pro-inflammatory reaction could activate the macrophages to produce ROS, which induces the apoptosis and involved in the subsequent plaque formation in the progression of AS progression. Lipooxygenase-1 (LOX-1) plays an important role in the boosting of inflammatory reaction ([@B58]; [@B54]). The uptake of ox-LDL into the endothelium interacts with LOX-1 receptor and induces the toxic side effect such as generation of ROS, secretion of pro-inflammatory cytokines, proapoptotic proteins, and overproduction of adhesion molecules ([@B7]; [@B15]). The nuclear level, central transcriptional (NF-κB) plays an important role in the activation of vascular endothelium during the atherosclerosis disease. Previous studies suggest that the NF-κB and generation of intracellular ROS both play a crucial role in the inflammatory reaction. Research suggests that the ox-LDL activates the NF-κB and augments the production of ROS in endothelial cells ([@B71]; [@B50]). Toll-like receptor 4 (TLR4) plays a vital role in the regulation and initiation of the immune response and induces remarkable proatherogenic and pro-inflammatory cytokines expression in endothelial cells and macrophages. Adaptor molecule such as myeloid differentiation factor 88 (Myd88) plays a crucial role in the TLR4 signaling pathway. Another inflammatory pathway such as NF-κB p65 altered the TLR4 pathway, resultant induces the expression of various pro-inflammatory mediators, which contributes to the atherosclerosis disease ([@B24]; [@B93]; [@B70]).

Pro-inflammatory cytokines, *viz*., interleukin-1 (IL-1) and interleukin-2 (IL-2), produced *via* macrophages exert inflammatory effects and induce the expansion of AS. It is believed that chronic inflammation plays an important factor in the progression of atherogenesis ([@B32]; [@B94]). Another inflammatory marker, *viz*., TNF-α and IL-6, played a crucial role in ox-LDL--induced inflammation. IL-6 shows the direct effect inflammatory, proatherogenic effect including activation of endothelial cells and platelet activation, enhances the vascular smooth muscle proliferation, and increases the production of ROS ([@B72]; [@B90]; [@B33]). Imbalance of cholesterol influx, efflux, and synthesis could interrupt the cholesterol homeostasis and start the generation of form cells. Due to the direct role of pro-inflammatory cytokines and alteration of intracellular ROS level, the researcher focuses on their research to treat the AS disease ([@B90]; [@B49]).

Materials and Methods {#s2}
=====================

Chemical {#s2_1}
--------

Ginkgolic acid (≥95.0%) ([**Figure 1**](#f1){ref-type="fig"}) was purchased from the Sigma Aldrich, USA.

![Structure of Ginkgolic acid.](fphar-10-01241-g001){#f1}

Cell Culture {#s2_2}
------------

Human microvascular endothelial cells (HMEC-1) were used for the current experimental study. The cells were cultured in the MCDB 131 medium containing fetal bovine serum (10%) and cells were cultured into the humidified air area containing CO2 at 37°C. The cells were treated with 200-μg oxidized LDL (ox-LDL) in the presence of ginkigolic acid (0--20 μM) for 1 day. After that, the biomarkers in the supernatant and cells were detected.

Cell Viability Assay {#s2_3}
--------------------

The cells were seeded overnight in 96-well plates and, afterward, mixed the ox-LDL and various concentration of ginkgolic acid into the wells at 37°C for 1 day. On the other hand, the vehicle control group contain DMSO (0.5%). The MTT assay was used for the determination of cytotoxicity. Briefly, MTT (100 μl) was added into the medium and left for next 4 h. Consequently, isopropanol (150 μl) was added into the medium for the next 15 min and finally calculated the absorbance at 570 nM *via* using the microplate reader. Meanwhile, the result was presented as the relative ratio as compared with the vehicle group.

Determination of ROS {#s2_4}
--------------------

Fluorescent probes DCFH2-DA was used for the estimation of intracellular ROS production *via* using the previous method with minor modification. The HMEC-1 cells were treated with the ox-LDL (200 μg) and ginkgolic acid, and subsequently, DCFH2-DA was added for 20 min at the temperature (37°C) in the dark place. For the estimation of intracellular ROS levels, fluorescence was used for excitation (488 nM) and emission (519 nM) *via* using the confocal microscope.

Lipid Peroxidation (Lpo) Assay {#s2_5}
------------------------------

For the estimation of LPO, malondialdehyde (MDA) production was estimated *via* using the previously reported method with minor modification ([@B87]; [@B17]). Briefly, 0.55-ml LDL was added in all tube and added the trichloroacetic acid (0.5%) to denature the protein. The sample was centrifuged at 10,000 rpm for 30 min at 10°C to separate the pellets. 0.5 ml of thiobarbituric acid (TBA) added in the supernatant and vigorously mixed the reagents to react for 40 min at 90--95°C in a dark room. After completion of the reaction, the absorbance was estimated at 532 nM (excitation) and 600 nM (emission).

Relative Electrophoretic Mobility {#s2_6}
---------------------------------

For REM, 200 μg/ml of LDL was pretreated with the various concentration of ginkgolic acid for 2 h and followed incubation at 37°C with CuSO~4~ (10 μM) for 16 h. LDL was estimated *via* using the agarose electrophoresis to estimation the increase in electrophoretic mobility. Briefly, modified LDL was loaded into agarose gels (0.6%) and electrophoresed at 100 V for 40 min.

ApoB Fragmentation {#s2_7}
------------------

After the oxidation in the presence and absence of ginkgolic acid, samples were denatured with 2-mercaptoethanol (5%), SDS (3%), and glycerol (10%) for 5 min at 95°C for the detection of polyacrylamide gel electrophoresis.

2,2-Diphenyl-1-Picrylhydrazyl (DPPH) Radical Scavenging Method {#s2_8}
--------------------------------------------------------------

For the estimation of the antiradical activity of ginkgolic acid, DPPH model was used *via* following the previously reported method with minor modification ([@B43]). Briefly, DPPH (0.2 nM) is freshly prepared *via* dissolving the DPPH in the methanol solution. Then, ginkgolic acid and trolox were added into the DPPH solution and finally estimated the concentration at 517 nM after the incubation of the sample mixture in room temperature.

Estimation of Mitochondrial Membrane {#s2_9}
------------------------------------

For the estimation, the effect of ginkgolic acid on the mitochondrial membrane has a potential *via* using the lipophilic cationic probe fluorochrome5,58,6,68-tetraethylbenzimidazolcarbocyanine iodide (JC-1) ([@B12]; [@B52]). JC-1 shows the potential dependent deposition in mitochondria as an indicator of fluorescence emission. After the treatment of ox-LDL for 16h with and without treatment of ginkgolic acid, the cells were washed with medium followed *via* the addition of JC-1, and finally, the cells were scrutinized *via* using the fluorescent microscope.

Pro-Inflammatory Cytokines Estimation {#s2_10}
-------------------------------------

For the estimation of inflammatory cytokines, the supernatants of HMEC-1 cells were collected after the ox-LDL and ginkgolic acid treatment. Pro-inflammatory cytokines such as TNF-α and IL-6 were quantified in the HMEC-1 cells *via* using the enzyme-linked immunosorbent assay (ELISA; R and D Systems, Minneapolis, MN, USA) by following the manufacturer's instruction.

Estimation of NF-κB Production {#s2_11}
------------------------------

After the ox-LDL and ginkgolic acid treated HMEC-1 cells, the nuclear extracts from the treated cells were prepared *via* using the Nuclear Extract Kit. NF-κB p65 assay kit was used for the estimation of NF-κB activity *via* using the (SN368, Beyotime Institute of Biotechnology, China) manufacture's instruction.

Preclinical Study {#s2_12}
-----------------

### Preparation of LDL {#s2_12_1}

For the collection of LDLs, the blood sample was withdrawn from the overnight fasted donor and kept in precooled vacuum tubes containing Na-EDTA. For the separation of the plasma, the samples were centrifuged at low speed at 1°C and kept the same temperature throughout the separation protocol. The LDL was successfully isolated from the plasma in the density interval of 1.025 to 1.050 kg/l by sequential preparative ultracentrifugation for 20. Lowry technique was used for the estimation of protein level in the LDL preparation.

### Oxidation of LDL *via* Copper {#s2_12_2}

Firstly, separate the EDTA from the isolated LDL *via* dialyzed in 0.02 mol/L phosphate/0.16 mol/L NaCl buffer, pH 7.4 for 15 h at low temperature (4°C). Copper-mediated oxidation of LDL was performed *via* incubating the EDTA-free LDL (0.2 mg/ml) in medium containing CuSO4 (10-5 mol/L) at 37°C for 12 h. Limulus assay was used for the analysis of presence or absence of endotoxins in the LDL preparations. In the whole procedure, the endotoxin levels should be less than 0.5 ng/ml in the stock solutions and less than 5 pg/ml in the test samples. The thiobarbituric acid reactive substance was used for the estimation of lipid peroxidize content in the native and oxidized LDL.

### Isolation of Human Peripheral Blood Mononuclear Cells {#s2_12_3}

For the isolation of human peripheral blood mononuclear cells, briefly, the isolated cells were cultured in collagen I coated plates and cultured in RPMI medium. The cells were dispersed in culture plates and incubated and different concentration of ginkgolic acid for 24 h. We further divided the groups as follows: Gp- I control, Gp II- ox-LDL, Gp-III ox-LDL+GA (5 μg/ml) and Gp-IV ox-LDL+GA (20 μg/ml). Furthermore, the cells were used for the estimation of lipoxygenase (LOX), cyclooxygenase (COX), prostaglandin E2 (PGE2), nitric oxide (NO), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), vascular cell adhesion molecule-1 (VCAM-1), nuclear factor-kappa B (NF-κB), and toll-like receptor 4 (TLR4) after the incubation (24 h).

### Cytotoxicity and NF-κB Transcription Assay {#s2_12_4}

Tetrazolium salt 3-(4-5-dimethylthiozol-2-yl) 2-5-diphenyl-tetrazolium bromide (MTT) assay was used for the estimation of cytotoxicity effect *via* using the previous method with minor modification.

NF-κB p65 nuclear translocation was estimated by using the standard kits *via* following the manufacturer's instruction (M/s Cayman chemicals, MI, USA).

### Estimation of Inflammatory Markers {#s2_12_5}

The inflammatory markers such as COX and LOX were estimated *via* using the previously published method with minor modification. NO activity was determined by using the previously published protocol of Kumar et al., with minor modification.

For the estimation of PGE2, available ELISA kits were used *via* the following manufacturer's instruction (M/s Cayman chemicals, MI, USA).

### Western Blot Technique {#s2_12_6}

Various parameters such as IL-6, VCAM-1, and TNF-α were estimated *via* using the western blot techniques. hPBMCs were washed with phosphate buffer saline (PBS) three times before the lysis on ice *via* using the 10 mmol/EDTA, 150 MMOL/NaCl, 10 mmol/Tris, 10 mmol/NaN3, 5 mmol/iodoacetamide, 1% NP-40, and 1 mmol/PMSF. Finally, the lysates were heated for 5 min in nonreducing sample buffer \[2% SDS, 0.001% bromophenol blue, 10 mmol/Tris (pH 6.8), 20% glycerol, and resolved *via* 8% SDS--polyacrylamide gel electrophoresis (PAGE)\]. The separated protein was successfully moved to the nitrocellulose membrane and blocked at room temperature for 1 h, and finally, the membrane was incubated with specific antibodies against primary antibodies for overnight at 4°C followed *via* conjugated with secondary antibodies for 60 min at 37°C. Diaminobenzidine substrate solution was used for the detection of antibodies.

### RT-PCR Analysis {#s2_12_7}

RNA isolation kits were used for the isolation of total cellular RNA *via* following the manufacturer's instruction, and finally, the UV spectroscopy was used for the quantification of isolated RNA *via* estimated the absorbance at 260 and 280 nM. The cDNA first strand was synthesized using the total RNA in the Eppendorf thermal cycler and the primer was added in the reaction mixture in the presence of dNTPs, reverse transcriptase, and RNase inhibitor. The reaction mixture was gently centrifuged for 5 min (25°C) followed *via* 1 *h* (42°C) for reverse transcription, and finally, the reaction was terminated *via* heating the reaction mixture for 5 min at 70°C. The sequences of the primers are presented in [**Table 1**](#T1){ref-type="table"}.

###### 

Showed the list of primers.

  ---------------------------------------------------------------------------------------
  S. No   Gene     Forward                             Reverse
  ------- -------- ----------------------------------- ----------------------------------
  1       TLR-4    5\' GCAGAAAATGCCAGGATGATG3\'        5\'GGCTGTCAGAGCCTCGTGGCTT\
                                                       TGG3\'

  2       TNF-α    5\' GCA GAA AAT GCCAGG ATG ATG3\'   5\'GGC TGT CAG AGC CTC\
                                                       GTG GCT TTG G3\'

  3       iNOS     5\'CAG CAC AGA GGG CTCAAA GC3\'     5\'TCG TCG GCC AGC TCTTTC T3\'

  4       VCAM-1   5\'-AAA AGC GGA GACAGG AGA CA-3\'   5\'-AGC ACG AGA AGCTCA GGA GA3\'

  5       IL-6     5\'CCA CTG CCT TCC CTACTT CA3\'     5\'TGG TCC TTA GCC ACTCCT TC3\'

  6       GAPDH    5\'TGAAGGTCGGTGTGAACGGATTT\         5\'CATGTAGGCCATGAGGTCCACC\
                   GGC3\'                              AC3\'
  ---------------------------------------------------------------------------------------

Statistical Analysis {#s2_13}
--------------------

For the statistical analysis, one-way ANOVA was used to identify the comparison between the different groups. Tukey test was used for the one-way ANOVA. Results are given as mean ± standard error of the mean.

Result {#s3}
======

Effect of Ginkgolic Acid on HMEC-1 Cell Viability {#s3_1}
-------------------------------------------------

MTT assay was performed for the estimation of a cytotoxicity study of ginkgolic acid on the HMEC-1 cell. For the MTT assay, 0--20 µM ginkgolic acid to choose for optimum dose to avoid cytotoxicity. MTT assay showed that the ginkgolic acid (5--20 µM) did not show any effect on the HMEC cell viability ([**Figures 2A, B**](#f2){ref-type="fig"}). [**Figure 2C**](#f2){ref-type="fig"} showed that the ginkgolic acid increased the cell viability in the ox-LDL--induced HMEC-1 cells.

![Showed the effect of ginkigolic acid on ox-LDL decreases HMEC-1 cell expansions indentify by MTT assay for **(A**, **B)** 24 and 48 h, **(C)** the cells (HMEC-1) treated with ginkigolic acid. Data are presented as Mean ± SEM, \*p \< 0.05, compared to the control group (without treatment), \^p \< 0.05, compared to ox-LDL group.](fphar-10-01241-g002){#f2}

Effect of Ginkgolic Acid on Oxidative Stress {#s3_2}
--------------------------------------------

[**Figure 3**](#f3){ref-type="fig"} showed the effect of ginkgolic acid on the intracellular ROS. For the estimation of oxidative stress, intracellular ROS were determined. The HMEC-1 cells treated with ox-LDL exhibited the increased intracellular ROS level. Ginkgolic acid treated HMEC-1 cell exhibited a reduced level of intracellular ROS in a concentration-dependent manner.

![Showed the effect of ginkigolic acid on ox-LDL--induced ROS level. Data are presented as Mean ± SEM, \*p \< 0.05, compared to the control group (without treatment), \^p \< 0.05, compared to ox-LDL group.](fphar-10-01241-g003){#f3}

Effect of Ginkgolic Acid on Inflammatory Cytokines {#s3_3}
--------------------------------------------------

For the estimation of the anti-inflammatory effect of ginkgolic acid, pro-inflammatory cytokines were estimated. Ox-LDL treated cells showed the increased level of pro-inflammatory cytokines such as IL-6, TNF-α, IL-8, and VCAM-1, and concentration-dependent treatment of ginkgolic acid significantly reduced the level of pro-inflammatory cytokines ([**Figure 4**](#f4){ref-type="fig"}).

![Showed the effect of ginkigolic acid on pro-inflammatory cytokines. **(A)** IL-6, **(B)** TNF-α and **(C)** IL-8 and **(D)** VACM-1. Data are presented as Mean ± SEM, \*p \< 0.05, compared to the control group (without treatment), \^p \< 0.05, compared to ox-LDL group.](fphar-10-01241-g004){#f4}

Effect of Ginkgolic Acid on Caspase and NF-κb {#s3_4}
---------------------------------------------

[**Figure 5**](#f5){ref-type="fig"} showed the effect on the caspase-3 and NF-κB in the ox-LDL and ginkgolic acid treated group. Ox-LDL treated group exhibited a reduced level of caspase-3 activity and increased the level of NF-κB activity. Ginkgolic acid significantly increased the caspase-3 activity and reduced NF-κB activity.

![Effect of ginkgolic acid on the caspase-3 and NF-κB activity on the ox-LDL treated group. **(A)** caspase-3 and **(B)** NF-κB activity. Data are presented as Mean ± SEM, \*p \< 0.05, compared to the control group (without treatment), \^p \< 0.05, compared to ox-LDL group.](fphar-10-01241-g005){#f5}

Effect of Ginkgolic Acid on the Inflammatory Marker in hPBMCs {#s3_5}
-------------------------------------------------------------

[**Figure 6**](#f6){ref-type="fig"} exhibited the effect of ginkgolic acid on the inflammatory mediator. Ox-LDL group exhibited the increased level of LOX, NO, and PGE~2~ and dose-dependent treatment of ginkgolic acid significantly reduced the level of LOX, NO, and PGE~2~.

![Showed the effect of ginkgolic acid on the NF-kB p65 Activity. Data are presented as Mean ± SEM, \*p \< 0.05, compared to ox-LDL group.](fphar-10-01241-g006){#f6}

Effect of Ginkgolic Acid on IL-6, TNF-α, and VCAM-1 in hPBMCs {#s3_6}
-------------------------------------------------------------

[**Figure 7**](#f7){ref-type="fig"} demonstrated the increased expression of IL-6, TNF-α, and VCAM-1 in the ox-LDL treated in hPBMCs. Ginkgolic acid treated group significantly (P \< 0.05) reduced the expression of IL-6, TNF-α, and VCAM-1.

![Showed the effect of ginkgolic acid on the TNF-α, IL-6 and VCAM-1 level of ox-LDL treated cell lines. **(A)** TNF-α, **(B)** IL-6 and **(C)** VCAM-1. Data are presented as Mean ± SEM, \*p \< 0.05, compared to ox-LDL group.](fphar-10-01241-g007){#f7}

Discussion {#s3_7}
----------

Studies suggest that the ox-LDL is the significant marker for identifying the cardiovascular disease ([@B45]; [@B6]). Ginkgolic acid may reduce oxidative stress and inflammation, both (oxidative stress and inflammation) concerned in enhancing the risk of cardiovascular diseases. Studies also suggest that the ginkgolic acid considerably reduced the adhesion, invasion, and migration of cancer cells. The current study scrutinized the beneficial effect of ginkgolic acid to reduce the NF-κB signaling pathway ([@B23]; [@B46]).

Previous research suggests that the MTT assay generally provide the information on the nature of noncytotoxicity cells *via* estimation of mitochondrial activity which is directly or indirectly concurrent to the cell viability, for both the attached and poorly attached cells ([@B62]; [@B73]). In the assay of MTT, the metabolically active cell decreases the MTT tetrazolium salt \[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide\] and generates the crystal, whereas nonreactive cell or dead cells do not form the crystal. We estimated the cytotoxicity effect of ginkgolic acid on the HMEC-1 cells *via* performing the MTT assay. Cell viability assay and ginkgolic acid (20 µM) exhibit the nontoxic effect against the HMEC-1 cells.

Research suggests that the ox-LDL plays a significant role in the initiation and the expansion of oxidative stress and malonaldehyde (MDA) is the considerable marker of LPO involved in the breakdown of LPO ([@B81]; [@B54]). HMEC-1 cells treated with ox-LDL exhibited the enhanced level of ROS and LPO product due to the formation of free radicals. Ginkgolic acid already confirmed their antioxidant nature because the hydroxyl group is found in the benzene ring system and eliminates the ROS ([@B58]; [@B54]). The current nature of ginkgolic acid may favor the reduction of ox-LDL. Ox-LDL significantly enhanced the intracellular ROS formation in HMEC-1 cells. Previous research suggests that ox-LDL is the strong inducer of ROS production. Ox-LDL was exhibited to boost the intracellular oxidation of DCFH dye, a process that has already been showed to depend on the production of intracellular ROS ([@B96]; [@B40]). Various free radicals, *viz*., hydrogen peroxide (H2O2), superoxide (·O~2~), NO, hydroxyl (·OH), peroxynitrite (·ONOO) radicals, generated the ROS in the endothelial cells ([@B67]; [@B13]). In the current experimental study, we observed the increased level of ROS and ginkgolic acid treatment significantly reduced the formation of ROS *via* reducing the generation of free radicals. The result suggests the antioxidant nature of ginkgolic acid *via* scavenging the ROS.

Research suggests that the vascular endothelial injury leads to induce vascular disease in patients ([@B86]; [@B59]). Ox-LDL is well known to trigger ECs to induce the production of chemotactic cytokines and adhesion molecules, attracting monocytes to the vascular wall for an inflammatory reaction ([@B92]; [@B74]). Theses mediators start the secretion of inflammatory cytokines that boost the migration and proliferation of smooth muscle cells resultant in atherosclerotic lesion development. The researcher focuses on their research to target the pro-inflammatory cytokines to scrutinize the protective effect of the drug. During atherosclerosis, pro-inflammatory cytokines such as TNF-α and IL-6 both have been related to vascular inflammation ([@B79]; [@B61]). TNF-α has a synergistic effect on monocyte adhesion and endothelial dysfunction ([@B77]). IL-6 increases the endothelial cell activation and induces the cell adhesion molecule expression such as VCAM-1, ICAM-1 and E-selectin on endothelial cells *via* trans-signaling ([@B60]). Research suggests the level of pro-inflammatory cytokines such as TNF-α and IL-6 secrete during the HMEC-1 cells ([@B21]; [@B76]). The increased level of IL-6 in ox-LDL appears due to inducing the oxidative stress in the cell ([@B29]). Boosting the level of IL-6, induce the inflammatory reaction and expand the cardiovascular disease. In our study, ginkgolic acid significantly reduced the level of IL-6 and suggesting the antioxidant and anti-inflammatory nature ([@B22]; [@B8]). The level of TNF-α, up-regulated during the ox-LDL treatment could be due to endothelial apoptosis. Ginkgolic acid considerably reduced the TNF-α level and reduced the ox-LDL--induced endothelial apoptosis. Based on the result, we can conclude that ginkgolic acid considerably reduced the pro-inflammatory cytokines in ox-LDL treated HMEC-1 cells.

The researcher suggests that the prostaglandins are the bioactive signaling molecule isolated from the cyclooxygenase (COX) involved in the inflammatory reaction, especially in the circulation/regulation of the pro-inflammatory cytokines ([@B48]; [@B63]; [@B85]). The continues generation of PGE~2~ was prominent in response to inflammatory stimuli. On the country, another inflammatory mediator such as 5-lipoxygenase (5-LOX) pathway mainly responsible for the fabrication of inflammatory lipid mediators having a significant role in the expansion of immunity along with it's as pro-atherogenic agents ([@B42]; [@B88]; [@B63]). In the current experimental study, ginkgolic acid significantly down-regulated the LOX and PGE~2~ activity in ox-LDL treated cells and suggesting the anti-inflammatory effect. Various other signaling pathways such as a nitric oxide (NO) play a crucial role in the pathogenesis of inflammation. NO is synthesized *via* nitric oxide synthases (NOSs), which are present in the various tissues ([@B89]). During the inflammation condition, endothelial nitric oxide synthase (eNOS) is responsible for the circulation of NO in the arteries and induced the inducible nitric oxide synthase ([@B19]; [@B27]). iNOS usually generates a higher amount of NO than eNOS and also plays a crucial role in the inflammation, apoptosis, and cellular damage. Previous research suggests that iNOS concurrently enhances O~2~ and NO production and nitrosative/oxidative stress in the atherosclerotic plaques ([@B11]; [@B64]). Our experimental study showed that the iNOS expression is enhanced in ox-LDL treated cells, which in turn signify the increase in NO production. The researcher suggests that the generated NO releases from the phagocytic and endothelial cells and reacts with the superoxide (O~2~) to produce the peroxynitrites ([@B18]). A similar effect was observed in our experimental study, ox-LDL showed the increased level of iNOS and NO and suggested the increased inflammatory reaction, and ginkgolic acid significantly reduced the NO and iNOS level, suggesting the anti-inflammatory effect.

NF-κB is a significant and ubiquitous transcription factor for genes that encrypt the cytokines including TNF-α and IL-6. Research suggests that the activation of NF-κB involves in the degradation of IκB protein ([@B3]). Phosphorylation of IκBα *via* cytokines, drugs viruses, and bacterial products quickly starts the degradation and translocation of NF-κB into the nucleus. After the activation of NF-κB, start the binding with the mRNAs expression and specific promoter elements of pro-inflammatory cytokines genes ([@B84]; [@B91]). Research suggests that the ox-LDL activates the NF-κB in smooth muscle cells, endothelial cells, and fibroblasts ([@B55]; [@B56]). NF-κB also activates during the expansion of early atherosclerotic lesions. In the current experimental study, we exhibit that ox-LDL activates the nuclear translocation of NF-κB p65 subunit and upregulate the inflammatory reaction in cultured hPBMCs, and GA treatment downregulated the nuclear translocation of NF-κB p65 subunit and also decreased the inflammatory response ([@B57]; [@B55]). The current action, due to its antioxidant property, could be responsible for its anti-oxidant and anti-inflammatory effects as well because most of the pro-inflammatory genes are under the control of NF-κB signaling pathway, and GA can counter regulate these pathways.

Conclusion {#s4}
==========

The current experimental study points toward the anti-inflammatory and antioxidant effect of ginkgolic acid against the ox-LDL--induced atherosclerosis. During the experimental study, GA played a preventive role against the ox-LDL--induced inflammation and oxidative stress in hPBMCs. The upregulation of pro-inflammatory cytokines in the ox-LDL group and translocation of NF- κB p65 subunit was observed to be downregulated *via* GA treatment. Furthermore, *in vivo* experimental investigation is warranted to explore the possible cardiovascular protective effect of ginkgolic acid in cardiovascular disease.
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